Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

The function of the hepatitis B e antigen (HBeAg) is largely unknown because it is not required for viral assembly, replication, or infection. In this report we chronicle clinical and experimental studies in an attempt to understand the role of HBeAg in natural infection. These studies largely have focused on clinical‐pathologic features of HBeAg‐negative variants in acute and chronic HBV infection, mutational analysis in animal models of hepadnavirus infection, and the use of transgenic murine models. The clinical and experimental data suggest that serum HBeAg may serve an immunoregulatory role in natural infection. To the contrary, cytosolic HBeAg serves as a target for the inflammatory immune response. These dual roles of the HBeAg and its ability to activate or tolerize T cells show the complexity of the interactions between the HBeAg and the host during HBV infection.

[1]  M. Mizokami,et al.  Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B , 1994, Digestive Diseases and Sciences.

[2]  M. Wulfsohn,et al.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. , 2003, The New England journal of medicine.

[3]  H. Isom,et al.  Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine‐resistant HBV in vitro , 2003, Hepatology.

[4]  S. Hadziyannis,et al.  Course of virologic breakthroughs under long‐term lamivudine in HBeAg‐negative precore mutant HBV liver disease , 2002, Hepatology.

[5]  R. Locksley,et al.  Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. , 2002, Immunity.

[6]  M. Brunetto,et al.  Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. , 2002, Journal of hepatology.

[7]  C. Chu,et al.  Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion , 2002, Journal of Clinical Microbiology.

[8]  S. Lee,et al.  Long‐term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen‐negative chronic hepatitis B in Taiwan , 2001, Journal of viral hepatitis.

[9]  H. Will,et al.  A dominant hepatitis B virus population defective in virus secretion because of several S‐gene mutations from a patient with fulminant hepatitis , 2001, Hepatology.

[10]  S. Hadziyannis,et al.  Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis B , 2001 .

[11]  J. Hoofnagle,et al.  Long‐term therapy of chronic hepatitis B with lamivudine , 2000, Hepatology.

[12]  K. Koike,et al.  Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region , 2000, American Journal of Gastroenterology.

[13]  M. Chen,et al.  Nondeletional T-Cell Receptor Transgenic Mice: Model for the CD4+ T-Cell Repertoire in Chronic Hepatitis B Virus Infection , 2000, Journal of Virology.

[14]  L. Solforosi,et al.  Molecular Epidemiology of an Outbreak of Fulminant Hepatitis B , 2000, Journal of Clinical Microbiology.

[15]  S. Günther,et al.  Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. , 2000, Virology.

[16]  O. Yokosuka,et al.  Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses. , 2000, Journal of hepatology.

[17]  Jian-She Wang,et al.  Infection of the fetus with hepatitis B e antigen via the placenta , 2000, The Lancet.

[18]  R. Purcell,et al.  Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection , 2000, Hepatology.

[19]  L. Stuyver,et al.  Three cases of severe subfulminant hepatitis in heart‐transplanted patients after nosocomial transmission of a mutant hepatitis B virus , 1999, Hepatology.

[20]  J. Summers,et al.  Enrichment of a Precore-Minus Mutant of Duck Hepatitis B Virus in Experimental Mixed Infections , 1999, Journal of Virology.

[21]  H. Trübel,et al.  Mutations in the basic core promotor and the precore region of hepatitis b virus and their selection in children with fulminant and chronic hepatitis B , 1999, Hepatology.

[22]  M. Buti,et al.  Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. , 1999, Hepatology.

[23]  H. Schlicht,et al.  Differential antigen-processing pathways of the hepatitis B virus e and core proteins. , 1999, Gastroenterology.

[24]  S. Günther,et al.  Functional analysis of HBV genomes from patients with fulminant hepatitis , 1998, Hepatology.

[25]  P. Wingfield,et al.  Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens. , 1998, Journal of molecular biology.

[26]  W. Zhai,et al.  Experimental study on pathogenicity of precore mutants in Hepadnaviridae. , 1998, Chinese Medical Journal.

[27]  K. Reifenberg,et al.  The Hepatitis B Virus e Antigen Cannot Pass the Murine Placenta Efficiently and Does Not Induce CTL Immune Tolerance in H-2bMicein Utero , 1998 .

[28]  M. Chen,et al.  The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. , 1998, Journal of immunology.

[29]  K. Koike,et al.  Precore wild‐type DNA and immune complexes persist in chronic hepatitis B after seroconversion: No association between genome conversion and seroconversion , 1998, Hepatology.

[30]  M. Chen,et al.  Role of B cells in antigen presentation of the hepatitis B core. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Morabito,et al.  A randomized, controlled trial of a 24‐month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum , 1997, Hepatology.

[32]  H. Tsubouchi,et al.  Response to Interferon-α2a in Patients with e Antigen-negative Chronic Hepatitis B , 1997 .

[33]  J. Quinn,et al.  Transmission of a homogenous hepatitis B virus population of A1896‐containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult , 1997, Hepatology.

[34]  M. Yaniv,et al.  A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant‐transmitted fulminant hepatitis B , 1997, Hepatology.

[35]  S. Chang,et al.  Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens , 1997, Journal of virology.

[36]  F. Schödel,et al.  The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype , 1997, Journal of virology.

[37]  K. Moriyama,et al.  Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. , 1996, Virology.

[38]  S. Günther,et al.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease , 1996, Journal of virology.

[39]  T. Liang,et al.  Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. , 1996, The Journal of clinical investigation.

[40]  F. Chisari,et al.  The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice , 1996, Journal of virology.

[41]  M. Chen,et al.  Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication , 1996, Journal of virology.

[42]  H. Will,et al.  Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation , 1996, Hepatology.

[43]  F. Chisari,et al.  DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. , 1996, Journal of immunology.

[44]  T. Baumert,et al.  Precore mutants revisited , 1996, Hepatology.

[45]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[46]  H. Okamoto,et al.  A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. , 1995, Kidney international.

[47]  F. Weizsäcker,et al.  Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants , 1995, Journal of medical virology.

[48]  M. Buti,et al.  Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations , 1995, Hepatology.

[49]  D. Persing,et al.  Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. , 1995, Gastroenterology.

[50]  S. Wolf,et al.  Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  U. Spengler,et al.  Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection , 1995, Journal of virology.

[52]  F. Schödel,et al.  Characterization of self‐reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice , 1995, European journal of immunology.

[53]  M. Loriot,et al.  Low frequency of precore hepatitis B virus mutants in anti‐hepatitis B e—positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B , 1995, Hepatology.

[54]  H. Okamoto,et al.  Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis , 1995, Annals of Internal Medicine.

[55]  P. Angus,et al.  Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation , 1995, Hepatology.

[56]  F Tsuda,et al.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen , 1994, Journal of virology.

[57]  G. Fattovich,et al.  Interferon therapy for the anti-HBe positive form of chronic hepatitis B. , 1994, Antiviral research.

[58]  S. Nagataki,et al.  Changes in the prevalence of HBeAg‐negative mutant hepatitis B virus during the course of chronic hepatitis B , 1994, Hepatology.

[59]  R. A. Crowther,et al.  Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy , 1994, Cell.

[60]  A. Lok,et al.  Detection of precore hepatitis B virus mutants in asymptomatic HBsAg‐positive family members , 1994, Hepatology.

[61]  O. Yokosuka,et al.  Coinfection study of precore mutant and wild‐type hepatitis B‐like virus in ducklings , 1994, Hepatology.

[62]  M. Alter,et al.  Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. , 1994, The Journal of clinical investigation.

[63]  F. Jirik,et al.  Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. , 1994, Journal of immunology.

[64]  D. Persing,et al.  Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. , 1993, Gastroenterology.

[65]  T. Maruyama,et al.  Role of T-cell tolerance in the persistence of hepatitis B virus infection. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[66]  T. Ishikawa,et al.  Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response. , 1993, Immunology.

[67]  K. Koike,et al.  Serology of acute exacerbation in chronic hepatitis B virus infection. , 1993, Gastroenterology.

[68]  Q. Zhang,et al.  Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region , 1993, Journal of virology.

[69]  H. Hsu,et al.  Hepatitis B Virus in the Colostra of HBeAg‐Positive Carrier Mothers , 1993, Journal of pediatric gastroenterology and nutrition.

[70]  H. Zentgraf,et al.  Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis , 1993, Journal of virology.

[71]  E. Tanzi,et al.  Is the course of perinatal hepatitis B virus infection influenced by genetic heterogeneity of the virus? , 1993, Journal of medical virology.

[72]  K. Koike,et al.  The serology of chronic hepatitis B infection revisited. , 1993, The Journal of clinical investigation.

[73]  R. Purcell,et al.  The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. , 1993, Virology.

[74]  O. Yokosuka,et al.  Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. , 1993, The Journal of clinical investigation.

[75]  H. Schlicht,et al.  A cysteine and a hydrophobic sequence in the noncleaved portion of the pre-C leader peptide determine the biophysical properties of the secretory core protein (HBe protein) of human hepatitis B virus , 1992, Journal of virology.

[76]  R. Purcell,et al.  The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host , 1992, Journal of virology.

[77]  G. Dusheiko,et al.  Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon‐α , 1992, Hepatology.

[78]  H. Hsu,et al.  Cellular Immune Response to HBcAg in Mother‐to‐Infant Transmission of Hepatitis B Virus , 1992, Hepatology.

[79]  M. Rugge,et al.  A randomized controlled trial of lymphoblastoid interferon‐α in patients with chronic hepatitis B lacking HBeAg , 1992, Hepatology.

[80]  S. Günther,et al.  Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. , 1992, Virology.

[81]  M. Milella,et al.  Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon. , 1992, Journal of hepatology.

[82]  O. Yokosuka,et al.  Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. , 1992, The Journal of clinical investigation.

[83]  J. Sung,et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.

[84]  F. Chisari,et al.  HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[85]  H. Thomas,et al.  Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis , 1991, Hepatology.

[86]  J. Wands,et al.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.

[87]  H. Will,et al.  Mechanism, kinetics, and role of duck hepatitis B virus e-antigen expression in vivo. , 1991, Virology.

[88]  H. Will,et al.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[89]  H. Okamoto,et al.  Hepatitis B Virus Mutants with Precore-Region Defects in Two Babies with Fulminant Hepatitis and Their Mothers Positive for Antibody to Hepatitis B e Antigen , 1991, Pediatric Research.

[90]  H. Okamoto,et al.  Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti‐HBe induced spontaneously or with interferon therapy , 1990, Hepatology.

[91]  A Valli,et al.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.

[92]  H. Okamoto,et al.  Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. , 1990, Gastroenterology.

[93]  J. Price,et al.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[94]  F Tsuda,et al.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen , 1990, Journal of virology.

[95]  R. Houghten,et al.  Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. , 1989, Journal of immunology.

[96]  H. Schaller,et al.  Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus , 1989, Journal of virology.

[97]  P. Wingfield,et al.  Comparative immunogenicity of hepatitis B virus core and E antigens. , 1988, Journal of immunology.

[98]  H. Schlicht,et al.  The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation , 1987, Journal of virology.

[99]  H. Varmus,et al.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication , 1987, Journal of virology.

[100]  D. Milich,et al.  The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. , 1986, Science.

[101]  Roger Williams,et al.  FULMINANT HEPATITIS B IN SUCCESSIVE FEMALE SEXUAL PARTNERS OF TWO ANTI-HBe-POSITIVE MALES , 1986, The Lancet.

[102]  M. Tong,et al.  Prevention of maternal‐infant hepatitis B virus transmission by immunization: The role of serum hepatitis B virus DNA , 1986, Hepatology.

[103]  F. Callea,et al.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. , 1986, Gastroenterology.

[104]  Kazuaki Takahashi,et al.  Maternofetal Transmission of IgG-Bound Hepatitis B e Antigen , 1982, Pediatric Research.

[105]  J. Squire,et al.  SECOND THOUGHTS ON THE WILLINK REPORT , 1960 .